Chicago Equity Partners LLC reduced its position in LifePoint Health, Inc. (NASDAQ:LPNT) by 58.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,590 shares of the company’s stock after selling 16,030 shares during the quarter. Chicago Equity Partners LLC’s holdings in LifePoint Health were worth $671,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in LifePoint Health by 1.3% in the second quarter. Vanguard Group Inc. now owns 3,310,467 shares of the company’s stock worth $222,299,000 after purchasing an additional 43,504 shares during the last quarter. LSV Asset Management grew its holdings in LifePoint Health by 83.5% in the second quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock worth $133,934,000 after purchasing an additional 907,469 shares during the last quarter. State Street Corp grew its holdings in LifePoint Health by 2.1% in the second quarter. State Street Corp now owns 1,132,914 shares of the company’s stock worth $76,075,000 after purchasing an additional 23,552 shares during the last quarter. Victory Capital Management Inc. grew its holdings in LifePoint Health by 19.3% in the third quarter. Victory Capital Management Inc. now owns 973,978 shares of the company’s stock worth $56,393,000 after purchasing an additional 157,831 shares during the last quarter. Finally, Prudential Financial Inc. grew its holdings in LifePoint Health by 15.0% in the second quarter. Prudential Financial Inc. now owns 645,041 shares of the company’s stock worth $43,314,000 after purchasing an additional 84,354 shares during the last quarter. 99.18% of the stock is currently owned by institutional investors and hedge funds.
LifePoint Health, Inc. (LPNT) opened at $44.10 on Friday. The stock has a market cap of $1,716.56, a price-to-earnings ratio of 11.11, a P/E/G ratio of 1.13 and a beta of 0.68. LifePoint Health, Inc. has a 1 year low of $42.50 and a 1 year high of $70.95. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24.
LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, October 27th. The company reported $0.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.15). The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.60 billion. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The company’s revenue for the quarter was down .7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.94 earnings per share. equities analysts anticipate that LifePoint Health, Inc. will post 3.65 EPS for the current fiscal year.
LifePoint Health declared that its board has initiated a share repurchase plan on Friday, October 27th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its stock is undervalued.
LPNT has been the topic of several analyst reports. ValuEngine lowered shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Zacks Investment Research raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Monday, September 11th. Credit Suisse Group initiated coverage on shares of LifePoint Health in a research note on Thursday, November 2nd. They set a “neutral” rating and a $54.00 price objective for the company. SunTrust Banks, Inc. set a $60.00 price objective on shares of LifePoint Health and gave the stock a “hold” rating in a research note on Thursday, October 12th. Finally, Piper Jaffray Companies reiterated a “hold” rating and set a $66.00 price objective on shares of LifePoint Health in a research note on Wednesday, October 4th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $60.23.
LifePoint Health Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.